CHDI is continually developing methods, tools, and other resources for all researchers working on Huntington's disease (HD). In addition to currently available reagents, protocols, and animal models, we are developing a digital platform, called Crossroads, for scientists investigating possible targets and compounds. This tool will be released to the HD research community within the next year.

If you would like information about our compound testing program, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

The Reagents page introduces the HD Community BioRepository, and explains how CHDI collaborators and other HD researchers can request these resources. Some Huntingtin antibodies are available through this resource. A list of other relevant antibodies that are commerically available can be downloaded from the Antibodies page.

In order to assist researchers and clinical investigators who are planning clinical trials or studies, a Global Site & Investigator Database for Huntington's Disease (GSID-HD) is under development. Once complete, the searchable database will containdetailed information on clinical site and investigator capabilities to help you identify research partners quickly and reliably. More information about how to register to be included in this resource is available on the GSID-HD page.

HD research has exploded since the discovery of the huntingtin gene in 1993, with more than 8,000 scientific publications listed on PubMed. For those looking for a way into the literature, this link will take you to a saved PubMed search. You can also learn more about the HD reseach topics discussed at recent workshops and meetings by going to the Workshops page.

If you are looking for a specific resource or are interested in clinical tools and programs, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it .